FTC Urges DC Circ. Not To Prolong Endo-Impax Monopoly

By Matthew Perlman (March 17, 2023, 6:55 PM EDT) -- The Federal Trade Commission urged the D.C. Circuit not to push back oral argument for the agency's bid to revive a case accusing Endo and Impax of splitting monopoly profits for a lucrative opioid, contending that the alleged conduct needs to be stopped now....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!